MENLO
PARK, Calif., Oct. 12,
2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced
today that it will hold its quarterly conference call to discuss
its third quarter 2023 financial results on Monday, October 30, 2023, at 4:30 pm Eastern Time.
The call will be webcast and may be accessed at PacBio's website
at: https://investor.pacificbiosciences.com/.
Date: Monday, October 30, 2023, at
4:30 pm ET (1:30 pm PT)
Listen live via internet or replay:
https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
If using the dial-in option, please dial into the call
ten minutes prior to start time using the appropriate number above
and ask to join the "PacBio Q3 Earnings Call."
About PacBio
Pacific Biosciences of California, Inc. is a premier life science
technology company that is designing, developing and manufacturing
advanced sequencing solutions to help scientists and clinical
researchers resolve genetically complex problems. Our products and
technology under development stem from two highly differentiated
core technologies focused on accuracy, quality and completeness
which include our existing HiFi long read sequencing and our
emerging SBB® short read sequencing technologies. Our products
address solutions across a broad set of research applications
including human germline sequencing, plant and animal sciences,
infectious disease and microbiology, oncology, and other emerging
applications. For more information please visit www.pacb.com and
follow @PacBio.
Contacts
Investors:
Todd Friedman
650.521.8450
ir@pacb.com
Media:
Lizelda Lopez
pr@pacb.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pacbio-to-report-third-quarter-2023-financial-results-on-october-30-2023-301955273.html
SOURCE Pacific Biosciences of California, Inc.